Topics

Bioverativ Inc., Company Profile

04:15 EST 24th February 2020 | BioPortfolio

Bioverativ, a Sanofi company, is dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development, and commercialization of innovative therapies. Bioverativ is committed to actively working with the blood disorders community, and its hemophilia therapies, when launched, represented the first major advancements in hemophilia treatment in more than two decades. For more information, visit www.bioverativ.com or follow @bioverativ on Twitter.


News Articles [4 Associated News Articles listed on BioPortfolio]

Sanofi writes down hemophilia drug as competitive pressures rise

A $2 billion impairment charge on Eloctate, acquired in Sanofi's 2018 Bioverativ buy, takes some shine off of a quarter boosted by surging Dupixent sales.

Oxford Biomedica (OXB) - Burgeoning bioprocessing revenues

Edison Investment Research - Pharmaceuticals & healthcare - Oxford Biomedica : Oxford BioMedica’s (OXB’s) interim results were broadly in line with our expectations for 2019. The decrease ...

Nimbus Therapeutics Appoints Accomplished Biologist and Research Director Christine Loh, Ph.D., to Lead Biology Team

Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today announced that it has appointed Christine Loh, Ph.D., as Senior Vic...

Torque Therapeutics Announces the Appointment of John Cox as Chief Executive Officer

Torque Therapeutics, a clinical stage, product-platform company developing proprietary, first-in-class Deep Primed™ adoptive cell transfer therapeutics with uniquely broad potential to treat patien...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Bioverativ Inc.,

Bioverativ, a Sanofi company, is dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development, and commer...

Bioverativ Inc.

Bioverativ (NASDAQ: BIVV) is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class resear...

Bioverativ Inc. & Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class re...

Bioverativ Inc. and Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class re...

Amunix Pharmaceuticals Inc.

Amunix Pharmaceuticals, based in Mountain View, CA, is a privately held drug discovery and development company with two proprietary technologies, XTEN® and ProTIA, that enable ...

More Information about "Bioverativ Inc.," on BioPortfolio

We have published hundreds of Bioverativ Inc., news stories on BioPortfolio along with dozens of Bioverativ Inc., Clinical Trials and PubMed Articles about Bioverativ Inc., for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bioverativ Inc., Companies in our database. You can also find out about relevant Bioverativ Inc., Drugs and Medications on this site too.

Quick Search

Relevant Topic

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...


Corporate Database Quicklinks



Searches Linking to this Company Record